| Database ID | Symbol | Body Site | Sample Type | Sample Name | Microbe | Project ID | AS Type | Group | Chr | PSI Visulization | Splicing Variant | Details |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2090462 | TP53I13 | Blood | Tissue | PSC-derived alveolar epithelial type II-like cells | Control/Healthy;COVID-19 | GSE152418 | A3SS | G0/G1 | 17 | - |
PV=1 FDR=1 FC=-0.163 |
|
| 2090463 | TP53I13 | Blood | Tissue | PSC-derived alveolar epithelial type II-like cells | Control/Healthy;COVID-19 | GSE152418 | A3SS | G0/G1 | 17 | - |
PV=0.87 FDR=1 FC=-0.007 |
|
| 2090464 | SARS2 | Blood | Tissue | PSC-derived alveolar epithelial type II-like cells | Control/Healthy;COVID-19 | GSE152418 | A3SS | G0/G1 | 19 | - |
PV=1 FDR=1 FC=0.041 |
|
| 2090465 | PLXNB2 | Blood | Tissue | PSC-derived alveolar epithelial type II-like cells | Control/Healthy;COVID-19 | GSE152418 | A3SS | G0/G1 | 22 | - |
PV=1 FDR=1 FC=-0.028 |
